ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,418.645
-0.11%
Brent Oil
82.19
-0.31%
Bitcoin
69,966.39
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vanda Pharmaceuticals Inc (VNDA) Share Price

VNDA Vanda Pharmaceuticals Inc

5.05
-0.22 (-4.17%)
22 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vanda Pharmaceuticals Inc NASDAQ:VNDA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.22 -4.17 5.05 5.03 5.24 5.2899 5.08 5.25 770,126 23:59:44   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 192.64M 2.51M 0.0436 117.20 294.02M
 Type  Size  Price  Time  Units 
 9 1 5.17 22:49:21 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VNDA News
21/05/202421:55EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
21/05/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
21/05/202421:52EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
21/05/202421:34EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
20/05/202422:26EDGAR2Form 8-K - Current report
15/05/202413:45PRNUSVanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
13/05/202421:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Period
Draw mode
Data Downloads for VNDA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Vanda Pharmaceuticals Inc Articles